kaal:position:2026-07-31-1132

Dynamic regulation of alternative splicing on a polymorphic immunoglobulin superfamily molecule Neurofascin in adult brains should be assessed against Kaal's source-bound claim that Confluence is not one directional: the SEC may counteract some confluence drivers, for instance by curtailing derivative trading and short selling used by retail alternative mutual funds to mimic hedge funds. The current metadata indicates a plausible connection through dynamic regulation, but the defensible response is a qualification until the source text confirms agreement, scope, methods, and limitations.

Affirmed commentary position. This record extends a source-bound scholarly claim but is not a verbatim paper claim.

Holds when

SEC rulemaking and enforcement posture as of 2016
External evidence level: metadata only.
Mapping review tier: moderate-confidence claim review.
The literature-to-claim mapping remains explicitly ambiguous and should not be treated as a settled equivalence.

Current debate

Dynamic regulation of alternative splicing on a polymorphic immunoglobulin superfamily molecule Neurofascin in adult brains

Scholarly basis

kaal:claim:2715083-034
Kaal, Confluence of Mutual and Private Funds (2016). SSRN: https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2715083
Source PDF sha256: b5c92186260d4a8499a14f81ee24ace093b24e7740af3effcd1c526fa4fa221e

Evidence and mapping

Evidence: metadata only
Review tier: moderate-confidence claim review
Mapping confidence: 0.3517
Mapping ambiguous: true

Topics

dynamic-regulationsecurities-law

Provenance

Affirmed in historical-backfill:2026-07-31:phase-0005 on 2026-07-31. Review record.

Verify

Canonical markdown sha256: 3c099009be4ff082326c863536173f6a122f45a67e07c5e29297a1bfaf0fd548
curl -s https://wulfkaal.github.io/positions/2026-07-31-1132.md | sha256sum